MatthysH, KöhlerD.Pulmonary deposition of aerosols by different mechanical devices. Respiration1985;48:269–276.
6.
LewisRA, EllisCJ, FlemingJS, BalachandranW.Ultrasonic and jet nebulizers: differences in the physical properties and fractional deposition on the airway responses to nebulized water and saline aerosols (abstract). Thorax1984;39:712.
7.
SwiftDL. Aerosol characterization and generation. In: MorenF, NewhouseMT, DolovichMB, eds. Aerosols in medicine: principles, diagnosis and therapy. Amsterdam: Elsevier, 1985:53–76.
8.
WoodJA, WilsonRSE, BrayC.Changes in salbutamol concentration in the reservoir solution of a jet nebuliser. Br J Dis Chest1986;80:164–169.
9.
StainforthJN, LewisRA, TattersfieldAE. Dosage and delivery of nebulized beta-agonists in hospital. Thorax1983;38:751–754.
10.
MurphyD, HolgateST. The use and misuse of domiciliary nebulizer therapy in the Isle of Wight. Respir Med1989;83:349–352.
11.
SteventonRD, WilsonRSE. A guide to apparatus for home nebuliser therapy. Research Triangle Park NC: Allen and Hanburys, 1986.
12.
SterkPJ, PlompA, Van der VateJF, QuanjerPH. Physical properties of aerosols produced by several jet and ultrasonic nebulisers. Bull Eur Physiopathol Respir1984;20:65–72.
13.
NewmanSP, PellowPGD, ClayMM, ClarkeSW. Evaluation of jet nebulisers for use with gentamicin solution. Thorax1985;40:671–676.
14.
SmithEC, KendrickAH. Comparison of apparatus for home nebuliser therapy (abstract). Thorax1990;45:817.
15.
JuniperEF, HargreaveFE. Airway responsiveness assessed by aerosol inhalation tests: variability in results due to unexpected differences between calibrated nebulizers (abstract). Bull Eur Physiopathol Respir1986;22(8, Suppl):165S.
16.
TsanakasJN, WilsonAJ, BoonAW. An evaluation of nebulisers for bronchial challenge tests (abstract). Bull Eur Physiopathol Respir1986;22(8, Suppl):138S.
17.
O'CallaghanC, ClarkAR, MilnerAD. Why nebulize for more than 5 minutes?Arch Dis Child1989;64:1270–1273.
18.
SmyeSW, ShawA, NorwoodHM, LittlewoodJM. Some factors influencing efficiency of a jet nebuliser system. Clin Phys Physiol Meas1990;11:167–175.
19.
ThomasSHL, LangfordJA, GeorgeRDG, GeddesDM. Improving the efficiency of drug administration with jet nebulisers (letter). Lancet1988;1:126.
20.
PisutFM. Comparison of medication delivery by T-nebulizer with inspiratory and expiratory reservoir. Respir Care1989;34:985–988.
21.
AsmundssonT, JohnsonRF, KilburnKH, GoodrichJR. Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis1973;108:506–512.
22.
LinMS, HayesTM, GoodwinGA, KruseSL. Distal penetration in radioaerosol inhalation with an ultrasonic nebuliser. Radiology1974;112:443–447.
23.
JohnsonMA, NewmanSP, BloomR, TalaeeN, ClarkeSW. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma: efficacy and pulmonary deposition. Chest1989;96:1–10.
24.
MontgomeryAB, DebsRJ, LuceJM, CorkeryKJ, TurnerJ, BrunetteEN, et al. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet1987;2:480–483.
25.
SimondsAK, NewmanSP, JohnsonMA, TalaeeN, LeeCA, ClarkeSW. Simple nebuliser modification to enhance alveolar deposition of pentamidine. Lancet1989;2:953.
26.
MacIntyreNR, SilverRM, MillerCW, SchulerF, ColemanRE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med1985;13:81–84.
27.
AhrensRC, RiesRA, PopendorfW, WieseJA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol1986;2:19–26.
28.
HughesJM, SaezJ.Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care1987;32:1131–1135.
RyanG, DolovichMB, ObminskiG, CockcroftDW, JuniperE, HargreaveFE, et al. Standardisation of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J Allergy Clin Immunol1981;67:156–161.
31.
RuffinRE, DolovichMB, WolffRK, NewhouseMT. The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis1978;117:485–492.
32.
NewmanSP, WoodmanG, ClarkeSW. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax1988;43:318–322.
33.
ZainuddinBM, TolfreeSEJ, ShortM, SpiroSG. Influence of breathing pattern on lung deposition and bronchodilator response to nebulized salbutamol in patients with stable asthma. Thorax1988;43:987–991.
34.
SalmonB, WilsonNM, SilvermanM.How much aerosol reaches the lungs of wheezy infants and toddlers?Arch Dis Child1990;65:401–403.
35.
DolovichMB, KillianD, WolffRK, ObminskiG, NewhouseMT. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis1977;115:397–402.
36.
IPPB Trial Group. IPPB in COPD. Chest 1984;86:341–342.
37.
ThomasSHL, LangfordJA, GeorgeRJD, GeddesDM. Aerosol deposition in the human lung: effect of high frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol. Clin Sci1988;75:535–542.
38.
O'DohertyM, ThomasS, PageC, BradbeerC, NunanT, BatemanN.Is upper lobe deposition of nebulised pentamidine improved by inhalation lying down? (abstract). Montreal, Canada: 5th International AIDS Conference, 1989:300.
39.
CollisGG, ColeCH, LeSouëfPN. Dilution of nebulised aerosols by air entrainment in children. Lancet1990;336:341–343.
40.
EverardML, ClarkAR, MilnerAD. Factors affecting drug delivery from jet nebulisers to patients (abstract). Thorax1990;45:817.
41.
LewisRA, FlemingJS. Fractional deposition from a jet nebuliser: how it differs from a metered dose inhaler. Br J Dis Chest1985;79:361–367.
42.
IlowiteJS, GorvoyJD, SmaldoneGC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis1987;136:1445–1449.
43.
HadfieldJW, WindebankWJ, BatemanJRM. Is driving gas flow clinically important for nebuliser therapy?Br J Dis Chest1986;80:50–54.
44.
DouglasJG, LeslieMJ, CromptonGK, GrantIWB. A comparative study of two doses of salbutamol nebulized at 4 and 8 L/min in patients with chronic asthma. Br J Dis Chest1986;80:55–58.
45.
KnightV, GilbertBE. Aerosol treatment of respiratory viral disease. Lung1990;168(Suppl):406–413.
46.
HubbardRC, CrystalRG. Strategies for aerosol therapy of alpha-antitrypsin deficiency by the aerosol route. Lung1990;168(Suppl):565–578.
47.
KöhlerD.Aerosols for systemic treatment. Lung1990;168(Suppl):677–684.
48.
ChinetT, CollignonM-A, DusserD, BarritaultL, HuchonGJ. Effectiveness of micronic aerosol generators and their aerosol characteristics. Eur J Respir Dis1986;69:153–159.
49.
ZimentI.A prescription for prescription writers (editorial). Respir Care1986;33:841–843.
50.
MallolJ, BarruetoL, GiradiG, MunozR, PuppoH, UlloaV, et al. Use of nebulized bronchodilators in infants under one year of age. Pediatr Pulmonol1987;3:298–303.
51.
FullerHD, DolovichMB, PosmituckG, Wong PackW, NewhouseMT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis1990;141:440–444.
52.
HodsonME, PenkethARL, BattenJC. Aerosol carbenicillin and gentamicin treatment of pseudomonas infection in patients with cystic fibrosis. Lancet1981;2:1137–1139.
53.
RaffertyP, BeasleyR, HolgateST. Comparison of the efficacy of preservative-free ipratropium bromide and Atrovent nebuliser solutions. Thorax1988;43:446–450.
54.
SnellNJC. Adverse reactions to inhaled drugs. Respir Med1990;84:345–348.
55.
Anonymous. The nebuliser epidemic (editorial). Lancet1984;2:789–790.
56.
CochraneGM, PriorJG, ReesPJ. Home nebulisers for airflow limitation (editorial). Br Med J1985;290:1608–1609.
57.
MorénF.Aerosol dosage forms and formulations. In: MorénF, NewhouseMT, DolovichMB, eds. Aerosols in medicine: principles, diagnosis and therapy. Amsterdam: Elsevier, 1985:261–287.
58.
HallworthGW. The formulation and evaluation of pressurized metered dose inhalers. In: GandertonD, JonesT, eds. Drug delivery to the respiratory tract. Chichester, England: Ellis Horwood, 1987:87–118.
59.
NewmanSP, PaviaD, MorenF, SheahanNF, ClarkeSW. Deposition of pressurized aerosols in the human respiratory tract. Thorax1981;36:52–55.
60.
DolovichMB, RuffinRE, RobertsR, NewhouseMT. Optimal delivery of aerosols from metered dose inhalers. Chest1981;83(Suppl):911–915.
61.
SpiroSG, SinghCA, TolfreeSEJ, PartridgeMR, ShortMC. Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis. Thorax1984;39:432–435.
62.
VidgrenMT, KarkkainenA, KarjalainenP, ParonenP.A novel labelling method for measuring the deposition of drug particles in the respiratory tract. Int J Pharm1987;37:239–244.
63.
KöhlerD, FleischerW, MatthysH.A new method for easy labelling of beta2-agonists in the metered dose inhaler with Tc99m. Respiration1988;53:65–73.
64.
ToogoodJH, BaskervilleJ, JenningsB, LefcoeNM, JohanssonS-A. Use of spacers to facilitate inhaled corticosteroid treatment in asthma. Am Rev Respir Dis1984;129:723–729.
65.
NewmanSP, PaviaD, ClarkeSW. How should a pressurized beta-adrenergic bronchodilator be inhaled?Eur J Respir Dis1981;62:3–20.
66.
RuffinRE, MontgomeryJM, NewhouseMT. Site of beta-adrenergic receptors in the respiratory tract. Chest1978;74:256–260.
67.
LindgrenS, BakeB, LarssonS.Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis1987;70:93–98.
68.
CromptonGK, DuncanJ.Clinical assessment of a new breath-actuated inhaler. Practitioner1989;233:268–269.
69.
WoodcockA.Training aid for pressurized inhalers. Br J Dis Chest1980;74:395–397.
70.
ShimC, WilliamsMH. The adequacy of inhalation of aerosol from canister nebulisers. Am J Med1980;65:891–894.
71.
AltounyanREC, ColeM, ClarkAR. Evaluation of an "open" spacer device for sodium cromoglycate (abstract). Eur J Respir Dis1983;64(Suppl 126):540.
72.
NewmanSP, WeiszA, ClarkeSW. Bronchodilator delivery from GentleHaler, a new low-velocity pressurized aerosol inhaler (abstract). Am Rev Respir Dis1990;141(4, Part 2):A18.
73.
CromptonGK. The adult patient difficulties with inhalers. Lung1990;168(Suppl):658–662.
74.
NewmanSP. Metered dose pressurized aerosols and the ozone layer. Eur Respir J1990;3:495–497.
75.
YarbroughJ, MansfieldLE, TingS.Metered dose inhaler-induced bronchospasm in asthmatic patients. Ann Allergy1985;55:25–27.
76.
BrownPH, BlundellG, GreeningAP, CromptonGK. Do large volume spacers reduce the systemic effects of high dose inhaled corticosteroids?Thorax1990;45:736–739.
77.
FarrerM, FrancisAJ, PearceSJ. Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 mL spacing device. Thorax1990;45:740–742.
78.
NewmanSP, MillarAB, Lennard-JonesTR, MorenF, ClarkeSW. Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax1984;39:935–941.
79.
DolovichMB, RuffinR, CorrD, NewhouseMT. Clinical evaluation of a new demand-inhalation MDI aerosol delivery device. Chest1983;84:36–41.
80.
VidgrenMT, ParonenP, KarkkainenA, KarjalainenP.Effect of extension devices on drug deposition from inhalation aerosols. Int J Pharm1987;39:107–112.
81.
KönigP.Spacer devices used with metered dose inhalers: breakthrough or gimmick?Chest1985;88:276–284.
82.
SelroosO.Use and limits of topical aerosols for topical treatment of granulomas and airflow obstruction in sarcoidosis. Sarcoidosis1986;3:126–127.
83.
SpiteriMA, NewmanSP, ClarkeSW, PoulterLW. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J1989;2:218–224.
84.
RusselG, FrameM.Terbutaline by Nebuhaler in young children. Practitioner1986;230:1043–1046.
85.
O'ReillyJF, GouldG, KendrickAH, LaszloG.Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma. Thorax1986;41:766–770.
86.
BisgaardH, MunckSL, NielsenJP, PetersenW, OhlssonSV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet1990;336:649–651.
87.
McCarthyTP. Nebulized budesonide in severe childhood asthma (letter). Lancet1989;1:379–380.
88.
MallolJ, BarruetoL, GirardiG, ToroO.Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device. Pediatr Pulmonol1987;3:352–356.
89.
SennhauserFH, SlyPD. Pressure-flow characteristics of the valve in spacer devices. Arch Dis Child1989;64:1305–1309.
90.
MorganMDL, SinghBV, FrameMF, WilliamsSJ. Terbutaline aerosol given through pear shaped spacer in acute severe asthma. Br Med J1982;285:849–850.
91.
FuglsangG, PedersenS.Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis1986;69:109–113.
92.
GervaisA, BeginP.Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization. Chest1987;92:822–824.
93.
TurnerJR, CorkeryKJ, EckmanD, GelbAM, LipavskyA, SheppardD.Equivalence of continuous flow nebulizer and metered dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest1988;93:476–481.
94.
NosedaA, YernaultJC. Sympathomimetics in acute severe asthma: inhaled or parenteral, nebulizers or spacer. Eur Respir J1989;2:377–382.
95.
JenkinsSC, HeatonRW, FultonTJ, MoxhamJ.Comparison of domiciliary nebulized salbutamol and salbutamol from a metered dose inhaler in stable chronic airflow limitation. Chest1987;91:804–807.
96.
MestitzH, CoplandJM, McDonaldCF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest1989;96:1237–1240.
97.
SimondsAK, NewmanSP, CoxD, ClarkeSW. Aerosol delivery during mechanical ventilation: nebuliser or Nebuhaler? (abstract). Thorax1990;45:315P.
98.
PedersenS.Optimal use of tube spacer aerosols in asthmatic children. Clin Allergy1985;15:473–478.
99.
NewmanSP, WoodmanG, MorenF, ClarkeSW. Bronchodilator therapy with Nebuhaler: how important is the delay between firing and inhaling?Br J Dis Chest1987;82:262–267.
ClarkAR, RachelevskyG, MasonPL, GoldenhershMJ, HollingworthA.The use of reservoir devices for the simultaneous delivery of two metered dose aerosols. J Allergy Clin Immunol1990;85:75–79.
102.
CromptonGK. Clinical use of dry powder systems. Eur J Respir Dis1982;122(Suppl):96–99.
103.
NewmanSP. Production of radioaerosols. In: ClarkeSW, PaviaD, eds. Aerosols and the lung. London: Butterworths, 1984:71–91.
104.
PerssonG, GruvstadE, StahlE.A new multiple dose powder inhaler (Turbuhaler) compared with a pressurized inhaler in a study of terbutaline in asthmatics. Eur Respir J1988;1:681–684.
105.
EngelT, HeinigJH, MallingH-J, ScharlingB, NikanderK, MadsenF.Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy1989;44:220–225.
106.
DrepaulBA, PaylerDK, QualtroughJE, PerryLJ, ReeveFBA, CharltonSC. Becotide or Becodisks? A controlled study in general practice. Clin Trials J1989;26:335–344.
107.
AnaniA, HigginsAJ, CromptonGK. Breath-actuated inhalers: comparison of terbutaline Turbuhaler with salbutamol Rotahaler. Eur Respir J1989;2:640–642.
108.
VidgrenMT, KarkkainenA, KarjalainenP, ParonenP, NuutinenJ.Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm1988;42:211–216.
109.
NewmanSP, MorenF, TrofastE, TalaeeN, ClarkeSW. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J1989;2:247–252.
110.
VidgrenMT, ParonenP, VidgrenP, VainioP, NuutinenJ.In-vivo evaluation of the new multiple dose powder inhaler and Rotahaler using gamma scintigraphy. Acta Pharm Nord1990;1:3–10.
111.
PedersenS.How to use a Rotahaler. Arch Dis Child1986;61:11–14.
112.
PedersenS, HansenOR, FuglsangG.Influence of inspiratory flowrate upon the effect of a Turbuhaler. Arch Dis Child1990;65:308–310.
113.
EngelT, HeinigJH, MadsenF, NikanderK.Peak inspiratory flowrate and inspiratory vital capacity of patients with asthma measured with and without a new dry powder inhaler device (Turbuhaler). Eur Respir J1990;3:1037–1041.
114.
HansenOR, PedersenS.Optimal inhalation technique with terbutaline Turbuhaler. Eur Respir J1989;2:637–639.
115.
RyrfeldtA.The bronchial circulation-a significant local distribution system in the lung in inhalation therapy?J Aerosol Med1990;3:165–168.